Home/CiMaas/Wilfred T.V. Germeraad
WT

Wilfred T.V. Germeraad

Chief Scientific Officer, Chief Operating Officer, Co-founder

CiMaas

Therapeutic Areas

CiMaas Pipeline

DrugIndicationPhase
Expanded Donor NK CellsCancerPre-clinical
NK Cell + Antibody CombinationCancerPre-clinical
CAR-NK Cell TherapySolid TumorsResearch